VANGL1 and gastric cancer: Dong et al. discovered that levels of tRF‐24‐V29K9UV3IU and its target genes (CCND2, FZD3, as well as VANGL1) in GC cells and tissues were suppressed, implying that tRF‐24‐V29K9UV3IU inhibits GC progression by suppressing cell migration, proliferation, as well as invasion, while enhancing cell apoptosis via regulation of the Wnt pathway.33